Dapagliflozin Treatment in Type 2 Diabetes
Clinical trial NCT04620590 · COMPLETED
Trial details
- NCT number
- NCT04620590
- Sponsor
- Emerald Clinical Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2023-05-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.